RCP Implementation

The Food and Drug Administration is forecasting a contract opportunity under the NAICS code 561990 for RCP Implementation, indicating a focus on other support services for health and human services agencies. The procurement is anticipated to support operational initiatives related to user fee commitments, potentially involving administrative, technical, or logistical services to facilitate the implementation of regulatory user fee programs. While the solicitation number and specific scope are not yet defined, the opportunity is posted with a projected release date in May 2026, allowing industry partners to prepare in advance. The point of contact for program inquiries is the Cder Acquisition Liaison at cderacquisitions@fda.hhs.gov, and the contracting officer details are pending. The place of performance and set-aside eligibility remain unspecified, suggesting the contract may be open to unrestricted competition unless further details are released. The organization is part of the agency's broader efforts to enhance regulatory efficiency through external support services, with the contract likely to require expertise in regulatory compliance, data management, or process optimization within the FDA’s center for drug evaluation and research. Interested vendors are encouraged to monitor the official opportunity forecast page for updates and eventual formal solicitation issuance.